GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TransGlobal Assets Inc (OTCPK:TMSH) » Definitions » Capex-to-Revenue

TransGlobal Assets (TransGlobal Assets) Capex-to-Revenue : 0.00 (As of Dec. 2011)


View and export this data going back to 2007. Start your Free Trial

What is TransGlobal Assets Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

TransGlobal Assets's Capital Expenditure for the six months ended in Dec. 2011 was $0.00 Mil. Its Revenue for the six months ended in Dec. 2011 was $0.12 Mil.

Hence, TransGlobal Assets's Capex-to-Revenue for the six months ended in Dec. 2011 was 0.00.


TransGlobal Assets Capex-to-Revenue Historical Data

The historical data trend for TransGlobal Assets's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TransGlobal Assets Capex-to-Revenue Chart

TransGlobal Assets Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11
Capex-to-Revenue
- - - - -

TransGlobal Assets Semi-Annual Data
Dec07 Dec08 Dec09 Dec10 Dec11
Capex-to-Revenue - - - - -

Competitive Comparison of TransGlobal Assets's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, TransGlobal Assets's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TransGlobal Assets's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TransGlobal Assets's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where TransGlobal Assets's Capex-to-Revenue falls into.



TransGlobal Assets Capex-to-Revenue Calculation

TransGlobal Assets's Capex-to-Revenue for the fiscal year that ended in Dec. 2011 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0.123
=0.00

TransGlobal Assets's Capex-to-Revenue for the quarter that ended in Dec. 2011 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0.123
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TransGlobal Assets  (OTCPK:TMSH) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


TransGlobal Assets Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of TransGlobal Assets's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


TransGlobal Assets (TransGlobal Assets) Business Description

Traded in Other Exchanges
N/A
Address
810 Pony Express Road, Cheyenne, WY, USA, 82009
TransGlobal Assets Inc provides customers with a wide range of high-quality CBD & THC products from its organically grown Clones, Teens and Mothers. Its self-sustaining Hemp Ranch will be vertically integrated from acres allocated, to outdoor cultivation and indoor greenhouses, to warehouses for processing farm-grown hemp into textiles, hempcrete & plastics and processing all-natural products.